Corvus Pharma Com (CRVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,036 | -36,375 | -25,289 | -14,992 | -6,347 |
| Depreciation Amortization | 185 | 1,242 | 928 | 560 | 211 |
| Accounts payable and accrued liabilities | 559 | 518 | 1,131 | 129 | -193 |
| Other Working Capital | 1,635 | 3,448 | 3,130 | 1,150 | 59 |
| Other Operating Activity | 909 | 3,310 | 1,650 | 1,388 | 634 |
| Operating Cash Flow | $-12,748 | $-27,857 | $-18,450 | $-11,765 | $-5,636 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 18,288 | -40,357 | -49,848 | -57,865 | -58,133 |
| PPE Investments | -111 | -2,199 | -1,586 | -1,487 | -614 |
| Investing Cash Flow | $18,177 | $-42,556 | $-51,434 | $-59,352 | $-58,747 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8 | 71,358 | 71,355 | 71,355 | 64,343 |
| Financing Cash Flow | $8 | $71,358 | $71,355 | $71,355 | $64,343 |
| Beginning Cash Position | 5,050 | 4,105 | 4,105 | 4,105 | 4,105 |
| End Cash Position | 10,487 | 5,050 | 5,576 | 4,343 | 4,065 |
| Net Cash Flow | $5,437 | $945 | $1,471 | $238 | $-40 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,748 | -27,857 | -18,450 | -11,765 | -5,636 |
| Capital Expenditure | -111 | -2,199 | -1,586 | -1,487 | -614 |
| Free Cash Flow | -12,859 | -30,056 | -20,036 | -13,252 | -6,250 |